Triplex-forming peptide nucleic acids induce heritable elevations in gamma-globin expression in hematopoietic...

Area of Science:

• Molecular Biology
• Gene Therapy
• Genetics

Background:

• Hemoglobinopathies like sickle cell disease result from β-globin mutations.
• Hereditary persistence of fetal hemoglobin (HPFH) involves γ-globin expression in adults, ameliorating these disorders.
• Normally, γ-globin expression is silenced in adults.

Purpose of the Study:

• To utilize triplex-forming peptide nucleic acids (PNAs) to induce homologous recombination for targeted gene editing.
• To create hereditary persistence of fetal hemoglobin (HPFH) mutations to increase γ-globin expression in adult cells.
• To investigate the regulation of induced γ-globin expression using a hypoxia-responsive element (HRE).

Main Methods:

• Employing triplex-forming PNAs and donor DNAs to mediate site-specific gene modification.
• Transfecting human cells, including bone marrow and hematopoietic progenitor cells (HPCs), with PNA-DNA complexes.
• Modifying the γ-globin promoter to introduce HPFH point mutations and an HRE.

Main Results:

• Achieved site-specific modification frequencies of 1.63% using PNA-enhanced recombination, compared to 0.29% with donor DNA alone.
• Successfully inserted HPFH mutations and an HRE into the γ-globin promoter.
• Demonstrated oxygen tension-regulated expression of the modified γ-globin gene.

Conclusions:

• Triplex-forming PNA-induced recombination is an effective strategy for targeted gene editing.
• This approach can successfully reactivate silenced fetal hemoglobin (γ-globin) gene expression in adult mammalian cells.
• The study demonstrates the potential of oligonucleotide-based gene therapy for treating hemoglobinopathies by regulating gene expression via an introduced HRE.